NIH-funded research R01 grant

Investigating how early life factors and genetics affect eosinophilic esophagitis

Official title: Early life factors, gene-environment interaction and eosinophilic esophagitis

Funded at Wake Forest University Health Sciences · NIH-10441396 · Data updated 2026-11-12

This study is looking at how things like antibiotic use, how babies are born, and breastfeeding might affect the chances of developing eosinophilic esophagitis (EoE) in people who are more likely to get it because of their genes, and it invites patients to share their early life experiences and genetic information to help us learn more about these connections.

More Eosinophilic Esophagitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startJuly 1, 2018
Project endJune 30, 2025
Funding year2023
Award (this year)$242,189
NIH project number5R01AI139126-05
Project IDNIH-10441396 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals under 21 years old who have been diagnosed with eosinophilic esophagitis or are at risk due to early life exposures.

Less likely to help

Patients who are over 21 years old or do not have a history of eosinophilic esophagitis may not benefit from this research.

What this research studies

This research explores how early life experiences, such as antibiotic use, delivery method, and breastfeeding, may influence the development of eosinophilic esophagitis (EoE) in individuals who are genetically predisposed. By examining the interactions between these early exposures and specific genetic markers, the study aims to identify risk factors for EoE. Patients may be asked to participate in a population-based registry-linkage study to gather comprehensive data on their early life factors and genetic information. The goal is to better understand how these elements contribute to the risk of developing EoE.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies and treatment options for eosinophilic esophagitis.

How similar studies have gone: Previous studies have shown promising results in understanding the relationship between early life exposures and eosinophilic esophagitis, suggesting that this research builds on established findings.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Jensen, Elizabeth T — Wake Forest University Health Sciences
  • Study coordinator: Jensen, Elizabeth T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.